5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.88▼ | 8.82▲ | 8.82▲ | 8.63▲ | 7.64▲ |
MA10 | 8.85▲ | 8.83▲ | 8.84▲ | 8.43▲ | 8.09▲ |
MA20 | 8.84▲ | 8.83▲ | 8.71▲ | 7.47▲ | 9.30▼ |
MA50 | 8.84▲ | 8.66▲ | 8.57▲ | 8.10▲ | 11.78▼ |
MA100 | 8.84▲ | 8.53▲ | 7.99▲ | 9.55▼ | 12.02▼ |
MA200 | 8.71▲ | 7.83▲ | 7.33▲ | 11.48▼ | 10.14▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.007▲ | -0.013▼ | -0.003▼ | 0.233▲ | 0.051▲ |
RSI | 50.754▲ | 55.739▲ | 58.966▲ | 63.733▲ | 45.290▼ |
STOCH | 75.092 | 43.012 | 66.061 | 85.128▲ | 38.834 |
WILL %R | -50.000 | -33.333 | -19.697▲ | -4.483▲ | -49.109 |
CCI | 42.241 | 69.976 | 68.839 | 89.572 | -4.019 |
Monday, April 28, 2025 07:08 AM
Short interest in Immunome Inc (NASDAQ:IMNM) increased during the last reporting period, rising from 11.13M to 12.48M. This put 14.92% of the company's publicly available shares short. Short ...
|
Thursday, April 17, 2025 03:41 PM
BOTHELL, Wash., April 04, 2025--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that ...
|
Thursday, April 17, 2025 03:41 PM
BOTHELL, Wash., April 04, 2025--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 8.75 | 8.99 | 8.53 | 8.86 | 717,282 |
30/04/25 | 8.33 | 8.94 | 8.31 | 8.79 | 1,120,302 |
29/04/25 | 8.61 | 8.79 | 8.34 | 8.54 | 808,812 |
28/04/25 | 8.42 | 8.70 | 8.3902 | 8.58 | 778,837 |
25/04/25 | 8.34 | 8.525 | 8.16 | 8.40 | 1,635,454 |
24/04/25 | 8.47 | 8.879 | 8.25 | 8.52 | 1,328,865 |
23/04/25 | 8.44 | 8.77 | 8.4075 | 8.50 | 799,245 |
22/04/25 | 8.15 | 8.36 | 7.9209 | 8.19 | 792,611 |
21/04/25 | 7.80 | 8.40 | 7.7557 | 8.00 | 882,578 |
17/04/25 | 7.13 | 7.96 | 6.9712 | 7.91 | 1,494,009 |
|
|
||||
|
|
||||
|
|